VANCOUVER, BC – January 30, 2023 – ISM Resources Corp. (“ISM” or the “Company”) (CSE: ISM), announces that, further to its news release of January 19, 2023, the company will complete a consolidation of the authorized and issued common shares of the Company (the “Common Shares”) on the basis of a one (1) post-consolidated Common Share for each two (2) pre-consolidation Common Shares (the “Consolidation”).

No fractional Common Shares will be issued upon the Consolidation. In the event a holder of Common Shares would otherwise be entitled to receive a fractional Common Share in connection with the Consolidation, the number of Common Shares to be received by such shareholder will be rounded down to the next whole number if that fractional Common Share is less than one half (1/2) of a Common Share, and will be rounded up to the next whole number of Common Shares if that fractional Common Share is equal to or greater than one half (1/2) of a Common Share.

Effective at the opening of markets on February 1, 2023, the Common Shares will commence trading on the Canadian Securities Exchange on a post-Consolidation basis under the existing ticker “ISM”. The new CUSIP number will be 45029H203 and the new ISIN number will be CA45029H2037.

Registered holders of Common Shares will receive a letter of transmittal from Endeavor Trust Corporation with instructions on how to exchange existing share certificates for new post-Consolidation share certificates.

On behalf of the Board of Directors,

“Glenn Collick”

Glenn Collick, President

ISM Resources Corp.

306-1110 Hamilton Street

Vancouver, BC V6B 2S2 i

nfo@ismresources.com

(778) 868-2226

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this news release

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up for Our Newsletter

Get the latest investment ideas and strategies sent straight to your inbox.

You May Also Like

Li-FT Starts Drilling at the Rupert Lithium Project, Quebec

Vancouver, British Columbia–(Newsfile Corp. – March 29, 2023) – Li-FT Power Ltd.…

Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol™ (formerly VRP324)

BERWYN, Pa., January 04, 2023–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:…

Tenet Provides Corporate Update Following Annual Meeting of Shareholders

Toronto, Ontario–(Newsfile Corp. – June 29, 2023) – Tenet Fintech Group Inc.…